93 3165 93 3165 Pill - pink capsule/oblong, 16mm
Pill with imprint 93 3165 93 3165 is Pink, Capsule/Oblong and has been identified as Minocycline Hydrochloride 50 mg. It is supplied by Teva Pharmaceuticals USA.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bullous Pemphigoid; Bartonellosis; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 3165 93 3165
Minocycline Hydrochloride
- Imprint
- 93 3165 93 3165
- Strength
- 50 mg
- Color
- Pink
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-3165 (Discontinued)
- Inactive Ingredients
-
corn starch,
magnesium stearate,
titanium dioxide,
D&C Red No. 33,
FD&C Red No. 3,
FD&C Yellow No. 6,
ferrosoferric oxide,
propylene glycol,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
shellac,
ammonia
Note: Inactive ingredients may vary.
Related images for "93 3165 93 3165"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Solodyn, Dynacin, Emrosi, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Emrosi, Minocin for Injection, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.